Gabler, a Texas native, has two decades of experience in the cardiology space, spending the last 11 years with Edwards Lifesciences. He has also previously worked for both Medtronic and Boston Scientific.

Juan Granada, MD, president and CEO of the Cardiovascular Research Foundation (CRF), shares his thoughts on two key areas of technology advancements in cardiovascular imaging and neuro-interventional care for stroke.

A new global report, based on data from 204 different countries and territories, has been published in full in the Journal of the American College of Cardiology.

Postural orthostatic tachycardia syndrome is a significant, but treatable condition. The risk among COVID-19 patients was considerably higher than the risk after vaccination, researchers explained. 

Acotec, founded in 2008, designs and distributes a wide range of medical devices used in interventional cardiology, including drug-coated balloons and thrombus aspiration catheters.

High out-of-pocket costs are a growing problem in healthcare, often creating stress and confusion for patients. A new analysis in Circulation: Cardiovascular Quality and Outcomes examined one way that physicians can help. 

The risk assessment tool could help health systems and researchers alike determine when patients face greater odds of post-PCI complications. 

New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.